References
- Brewerton D A, Hart F D, Nicholls A, Caffrey M, James D CO, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973; i: 904–7
- Tiwari J L, Terasaki PI. HLA and disease associations. Springer, New York 1985
- Todd JA. Genetic control of autoimmunity in type 1 diabetes. Immunol Today 1990; II: 122–9
- Benjamin R J, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 137–42
- von Boehmer H, Teh H S, Kisielow P. The thymus selects the useful, neglects the useless and destroys the harmful. Immunol Today 1989; 10: 57–61
- Bevan MJ. Class discrimination in the world of immunology. Nature 1987; 325: 192–4
- Nuchtern J G, Bonifaciano J S, Biddison W E, Klausner RD. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 1989; 339: 223–6
- Bjorkman P J, Saper M A, Samraoui B, Bennett W S, Strominger J L, Wiley DC. Structure of the human histocompatibility antigen, HLA-A2. Nature 1987; 329: 506–12
- Bjorkman P J, Saper M A, Samraoui B, Bennett W S, Strominger J L, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987; 329: 512–8
- St Charles R, Walz D A, Edward B FP. The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution. J Biol Chem 1989; 264: 2092–9
- Salter R D, Benjamin R J, Wesley PK, et al. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 1990; 345: 41–6
- Connolly J M, Hansen T H, Ingold A L, Potter TA. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I a3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc Natl Acad Sci USA 1990; 87: 2137–41
- Bjorkman P J, Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem, 59: 253–88
- Parham P, Lomen C E, Lawlor DA, et al. The nature of polymorphism in HLA-A,B,C molecules. Proc Natl Acad Sci USA 1988; 85: 4005–9
- Hughes A L, Nei M. Patterns of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 1988; 335: 167–70
- Parham P, Lawlor D A, Lomen C E, Ennis PD. Diversity and diversification of HLA-A,B,C alleles. J Immunol 1989; 142: 3937–50
- Wu T T, Rabat EA. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 1970; 132: 211–50
- Marsh S GE, Bodmer JG. HLA-DR and DQ epitopes and monoclonal antibody specificity. Immunol Today 1989; 10: 305
- Keat A. Is spondylitis caused by Klebsiella?. Immunol Today 1986; 7: 144–9
- de Castro López JA. HLA-B27 and HLA-A2 subtypes: Structure, evolution and function. Immunol Today 1989; 10: 239–46
- Garrett T PJ, Saper M A, Bjorkman P J, Strominger J L, Wiley DC. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989; 342: 692–6
- Choo S Y, Hansen JA. Human immunology, program and abstracts. Elsevier, (15th Annual ASHI Meeting). Abstr. 4.2-02
- Parham P, Lawlor D A, Salter R D, Lomen C E, Ennis PD. HLA-A,B,C: Patterns of polymorphism in peptide binding proteins. Immunobiology of HLA, B Dupont. Springer, New York 1989; vol. II.
- El-Zaatari F AK, Sams K L, Taurog JD. In vitro mutagenesis of HLA-B27: Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain. J Immunol 1990; 144: 1512–7
- Ways J P, Lawlor D, Wan A M, Parham P. A transposable epitope of HLA-B7, B40 molecules. Immunogenetics 1987; 139: 936–41
- Leiter E H, Serreze D V, Prochazka M. The genetics and epidemiology of diabetes in NOD mice. Immunol Today 1990; 11: 147–9